HYDROCELL Trademark

Trademark Overview

On Friday, January 31, 2020, a trademark application was filed for HYDROCELL with the United States Patent and Trademark Office. The USPTO has given the HYDROCELL trademark a serial number of 88781428. The federal status of this trademark filing is REGISTERED as of Tuesday, June 8, 2021. This trademark is owned by Allergan, Inc.. The HYDROCELL trademark is filed in the Pharmaceutical Products category with the following description:

Glycerin based ingredient sold as integral component of ophthalmic preparations; glycerin based ingredient sold as integral component of eye drops; glycerin based ingredient sold as integral component of lubricating and rewetting solutions for eyes

General Information

Serial Number88781428
Word MarkHYDROCELL
Filing DateFriday, January 31, 2020
Status700 - REGISTERED
Status DateTuesday, June 8, 2021
Registration Number6381438
Registration DateTuesday, June 8, 2021
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 31, 2020

Trademark Statements

Pseudo MarkHYDRO CELL
Goods and ServicesGlycerin based ingredient sold as integral component of ophthalmic preparations; glycerin based ingredient sold as integral component of eye drops; glycerin based ingredient sold as integral component of lubricating and rewetting solutions for eyes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, February 6, 2020
Primary Code005
First Use Anywhere DateTuesday, May 7, 2019
First Use In Commerce DateMonday, August 17, 2020

Trademark Owner History

Party NameAllergan, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressIrvine, CA 92612
US
Party NameAllergan, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIrvine, CA 92612
US
Party NameAllergan, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIrvine, CA 92612
US

Trademark Events

Event DateEvent Description
Tuesday, February 4, 2020NEW APPLICATION ENTERED
Thursday, February 6, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, February 22, 2020ASSIGNED TO EXAMINER
Wednesday, February 26, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 11, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 31, 2020PUBLISHED FOR OPPOSITION
Tuesday, March 31, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 26, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, December 28, 2020ABANDONMENT - NO USE STATEMENT FILED
Monday, December 28, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Tuesday, January 5, 2021TEAS PETITION TO REVIVE RECEIVED
Tuesday, January 5, 2021PETITION TO REVIVE-GRANTED
Tuesday, January 5, 2021SOU EXTENSION RECEIVED WITH TEAS PETITION
Wednesday, January 6, 2021NOTICE OF REVIVAL - E-MAILED
Monday, March 22, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, November 27, 2020SOU EXTENSION 1 FILED
Monday, March 22, 2021SOU EXTENSION 1 GRANTED
Tuesday, March 23, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 24, 2021TEAS STATEMENT OF USE RECEIVED
Wednesday, March 24, 2021USE AMENDMENT FILED
Friday, April 2, 2021STATEMENT OF USE PROCESSING COMPLETE
Tuesday, May 4, 2021SU-EXAMINER'S AMENDMENT WRITTEN
Tuesday, May 4, 2021EXAMINERS AMENDMENT E-MAILED
Tuesday, May 4, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, May 4, 2021EXAMINER'S AMENDMENT ENTERED
Tuesday, May 4, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, May 5, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, June 8, 2021REGISTERED-PRINCIPAL REGISTER
Monday, June 8, 2026COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

hydrocell component glycerin sold integral ingredient based solutions eyes rewetting ophthalmic